Article citationsMore>>
Bihrer, V., Friedrich-Rust, M., Kronenberger, B., Forestier, N., Haupenthal, J., Shi, Y., Peveling-Oberhag, J., Radeke, H.H., Sarrazin, C., Herrmann, E., Zeuzem, S., Waidmann, O. and Piiper, A. (2011) Serum miR-122 as a Biomarker of Necroinflammation in Patients with Chronic Hepatitis C Virus Infection. American Journal of Gastroenterology, 106, 1663-1669.
http://dx.doi.org/10.1038/ajg.2011.161
has been cited by the following article:
-
TITLE:
The Role of Circulating MicroRNAs as Markers of Disease Progression in Hepatitis C Virus Infected Egyptian Patients
AUTHORS:
Reem Abdel Hamid Harfoush, Marwa Ahmed Meheissen, Reham Abel Haleem Abo Elwafa, Doaa Ahmed Elwazzan
KEYWORDS:
MicroRNA, Hepatocellular Carcinoma, Hepatitis C Virus
JOURNAL NAME:
Advances in Microbiology,
Vol.6 No.4,
April
20,
2016
ABSTRACT: Background: The discovery of miRNAs circulating in the peripheral blood has opened new directions
of research to identify new non-invasive markers for diagnosis of diseases. Aim: The aim of the study
was to evaluate the expression levels of circulating plasma miRNAs (miRNA-21 & miRNA-122) in
Egyptian patients with chronic uncomplicated and complicated HCV. Patients & Methods: This study
was conducted on 60 Chronic HCV infected patients. Patients were divided into three groups (20 patients
each): uncomplicated HCV, cirrhosis, and hepatocellular carcinoma (HCC). All patients were
subjected to laboratory investigations including complete blood picture, liver function tests. Expression
levels of miRNA-21 and -122 in plasma using RT-PCR were determined. Results: MiRNA-21 showed significant fold increase in chronic uncomplicated HCV while significant fold decrease
in cirrhotic and HCC groups (P = 0.036). On the other hand, miRNA-122 showed significant fold elevation
in both chronic uncomplicated and cirrhotic groups and significant fold decrease in HCC
group (P = 0.005). ROC curve analysis for miRNA-122 yielded 68.4% sensitivity and 100% specificity
for the differentiation of HCC patients from non-HCC at a cutoff 0.184. Neither miRNA-21 nor miRNA-122 was a successful predictor for HCC diagnosis. Conclusion: MiRNA-122 can be used as novel
non-invasive biomarker for monitoring HCV related disease progression.
Related Articles:
-
Mohamed Abdel-Fattah El-Feki, Nilly Helmy Abdalla, Mohamed Ibrahim Atta, Ahmed Amin Ibrahim
-
Tomader Taha Abdel Rahman, Marwa Abdel Azeem Abdel Guaad, Ahmad Kamel Mortagy
-
Naoki Hotta
-
Ben Ilunga Bulanda, Berry Ikolango Bongenya, Jean-Yves Debels Kabasele, Médard Omakoy Okonda, Divine Chuga, Christian Tshisumbu, Elvis Tshunza Kateba, Erick Ntambwe Kamangu
-
Mamert Fulgence Yao Bathaix, Dramane Soro, Aboubacar Demba Bangoura, Adjéka Stanislas Doffou, Siaka Koné, Ya Henriette Kissy, Dimitri Hartrydt Kouamé, Aoudi Ousmane Dé, Mahassadi Kouamé Alassane, Attia Koffi Alain, Aya Thérèse N’dri Yoman